Hyong Kim

Title(s)	Clinical Professor, Medicine
School	Vc-health Sciences-schools
Address	9500 Gilman Drive # La Jolla CA 92093
vCard	Download vCard

Overview

Websites

Clinical Profile

ORNG Applications

Clinical Trials

Bibliographic

Publications

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.

Altmetrics Details

PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.

Safety of Macitentan for the Treatment of Portopulmonary Hypertension: Real-World Evidence from the Combined OPUS/OrPHeUS Studies. Pulm Ther. 2024 Mar; 10(1):85-107. Kim NH, Chin KM, McLaughlin VV, DuBrock H, Restrepo-Jaramillo R, Safdar Z, MacDonald G, Martin N, Rosenberg D, Solonets M, Channick R. PMID: 38184507; PMCID: PMC10881949.

View in: PubMed Mentions:
Patient and disease characteristics of the first 500 patients with pulmonary arterial hypertension treated with selexipag in real-world settings from SPHERE. J Heart Lung Transplant. 2021 04; 40(4):279-288. Kim NH, Hemnes AR, Chakinala MM, Highland KB, Chin KM, McLaughlin V, Zhao C, Narayan V, Farber HW. PMID: 33526303.

View in: PubMed Mentions: 4 Fields:
Car Cardiology Pul Pulmonary Medicine Tra Transplantation
Translation:Humans
Group 4 Pulmonary Hypertension: Chronic Thromboembolic Pulmonary Hypertension: Epidemiology, Pathophysiology, and Treatment. Cardiol Clin. 2016 Aug; 34(3):435-41. Kim NH. PMID: 27443139.

View in: PubMed Mentions: 28 Fields:
Car Cardiology
Translation:Humans
Chronic thromboembolic pulmonary hypertension: the evolving treatment landscape. Eur Respir Rev. 2015 Jun; 24(136):173-7. Kim NH, Mayer E. PMID: 26028629; PMCID: PMC9487821.

View in: PubMed Mentions: 4 Fields:
Pul Pulmonary Medicine
Translation:Humans
Chronic thromboembolic pulmonary hypertension. J Am Coll Cardiol. 2013 Dec 24; 62(25 Suppl):D92-9. Kim NH, Delcroix M, Jenkins DP, Channick R, Dartevelle P, Jansa P, Lang I, Madani MM, Ogino H, Pengo V, Mayer E. PMID: 24355646.

View in: PubMed Mentions: 164 Fields:
Car Cardiology
Translation:Humans Animals
Risk factors for chronic thromboembolic pulmonary hypertension. Eur Respir Rev. 2012 Mar 01; 21(123):27-31. Kim NH, Lang IM. PMID: 22379171; PMCID: PMC9487479.

View in: PubMed Mentions: 40 Fields:
Pul Pulmonary Medicine
Translation:Humans
Riociguat: an upcoming therapy in chronic thromboembolic pulmonary hypertension? Eur Respir Rev. 2010 Mar; 19(115):68-71. Kim NH. PMID: 20956169; PMCID: PMC9491640.

View in: PubMed Mentions: 8 Fields:
Pul Pulmonary Medicine
Translation:Humans
Assessment of operability in chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc. 2006 Sep; 3(7):584-8. Kim NH. PMID: 16963538.

View in: PubMed Mentions: 19 Fields:
Pul Pulmonary Medicine
Translation:Humans
Diagnosis and evaluation of the patient with pulmonary hypertension. Cardiol Clin. 2004 Aug; 22(3):367-73, v-vi. Kim NH. PMID: 15302357.

View in: PubMed Mentions: 1 Fields:
Car Cardiology
Translation:Humans